Neil Desai - 08 Sep 2021 Form 4 Insider Report for Aadi Bioscience, Inc. (WHWK)

Role
President and Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Lance Thibault, as Attorney-in-Fact
Issuer symbol
WHWK
Transactions as of
08 Sep 2021
Net transactions value
$0
Form type
4
Filing time
10 Sep 2021, 17:05:21 UTC
Previous filing
31 Aug 2021
Next filing
22 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AADI Stock option (right to buy) Award $0 +125,000 $0.000000 125,000 08 Sep 2021 Common Stock 125,000 $27.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the same day as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) such that all shares of common stock subject to the option shall be fully vested on the four year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean September 8, 2021.

Remarks:

President and Chief Executive Officer